Insights from Flagship Biosciences’ team of multidisciplinary experts.
Tumor Agnostic Approval Signals New Phase for Precision Medicine
Share this Post: In an important first, the FDA recently granted accelerated approval to Keytruda® for an indication that is based on a common biomarker
June 21, 2017
WSI System clearance for primary diagnosis expands clinical application of digital pathology
Back to Blog Share this Post: On April 12, 2017, FDA granted marketing clearance for the Philips IntelliSite Pathology Solution (PIPS), the first Whole Slide
May 9, 2017
Combining Genomic Profiling and Tissue-Based Biomarker Assays to Aid in the Early Detection and Prevention of Cancer
Back to Blog Share this Post: Genomic sequencing of precancerous lesions to improve prevention and early detection of cancer was a major focus at the
April 19, 2017
The Role of cTA™ In Bringing IO 360° Full Circle
Back to Blog Share this Post: The 3rd annual Immuno-Oncology 360° meeting, #IO360nyc, took a 360-degree view of the IO space with the first day
February 17, 2017
